Winton Group’s Viemed Healthcare VMD Stock Holding History

Winton Group’s Portfolio VMD Stock Details VMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-22,597	Closed	-$156K	–	1049
2025 Q2	$156K	Buy	+22,597	New	+$153K	0.01%	761
2024 Q4	–	Sell	-62,117	Closed	-$455K	–	793
2024 Q3	$455K	Sell	62,117 -21,678	-26%	-$155K	0.03%	456
2024 Q2	$549K	Buy	83,795 +60,727	+263%	+$458K	0.04%	411
2024 Q1	$218K	Buy	+23,068	New	+$198K	0.02%	552

Other funds holding VMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KLP

Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Winton Group's VMD Position: Q3 2025 in Review

Winton Group sold out of Viemed Healthcare (VMD) in Q3 2025, closing a stake of 22,597 shares — an estimated $156K sold.

Winton Group first reported a position in VMD in Q1 2024 and held it in 4 quarters. The position peaked at $549K in Q2 2024. 131 funds tracked by Wall St. Rank hold VMD as of Q3 2025.

Winton Group reported no remaining Viemed Healthcare position as of Q3 2025 after selling out during the quarter.
Winton Group sold 22,597 Viemed Healthcare shares in Q3 2025, an estimated $156K.
Winton Group first reported a position in Viemed Healthcare in Q1 2024 and held it in 4 quarters.
Winton Group's Viemed Healthcare position peaked at $549K in Q2 2024.
131 funds tracked by Wall St. Rank held Viemed Healthcare as of Q3 2025.

Based on Winton Group's 13F filing for Q3 2025, filed 13 Nov 2025.